- conflicts or gaps
- [[{"field": {"value": "total_funding_usd", "source_urls": ["https://www.cbinsights.com/company/isabl", "https://www.linkedin.com/company/isabl", "https://tracxn.com/d/companies/isabl/__tCqM6mim5rFSa3O76LHcICp2rRqXci47XXjfSZQTL7s/funding-and-investors"]}, "conflict": {"value": "CB Insights and Tracxn report $3M total raised (equity only); LinkedIn reports $5.1M total across 4 rounds; combined seed ($3M) plus NCI SBIR (~$2.03M) implies ~$5M total", "source_urls": ["https://www.cbinsights.com/company/isabl", "https://www.linkedin.com/company/isabl", "https://www.inknowvation.com/sbir/companies/isabl-inc", "https://tracxn.com/d/companies/isabl/__tCqM6mim5rFSa3O76LHcICp2rRqXci47XXjfSZQTL7s/funding-and-investors"]}}, {"field": {"value": "employee_count", "source_urls": ["https://www.ycombinator.com/companies/isabl/jobs", "https://www.linkedin.com/company/isabl", "https://www.thecompanycheck.com/company/b/isabl/65n7msaimutrsrzz3"]}, "conflict": {"value": "YC lists team size 5; LinkedIn lists 6 employees; TheCompanyCheck lists 3 employees as of Dec 31, 2024; company website lists 8 named team members", "source_urls": ["https://www.ycombinator.com/companies/isabl/jobs", "https://www.linkedin.com/company/isabl", "https://www.thecompanycheck.com/company/b/isabl/65n7msaimutrsrzz3", "https://www.isabl.io/company"]}}, {"field": {"value": "latest_funding_round_type", "source_urls": ["https://www.cbinsights.com/company/isabl", "https://tracxn.com/d/companies/isabl/__tCqM6mim5rFSa3O76LHcICp2rRqXci47XXjfSZQTL7s/funding-and-investors"]}, "conflict": {"value": "CB Insights labels latest round as Angel; Tracxn and TheCompanyCheck label most recent as Grant (Apr 2023); prior equity round reported as Seed (2022)", "source_urls": ["https://www.cbinsights.com/company/isabl", "https://tracxn.com/d/companies/isabl/__tCqM6mim5rFSa3O76LHcICp2rRqXci47XXjfSZQTL7s/funding-and-investors", "https://www.thecompanycheck.com/company/b/isabl/65n7msaimutrsrzz3"]}}, {"field": {"value": "seed_round_timing", "source_urls": ["https://www.360dx.com/molecular-diagnostics/msk-starts-offering-pediatric-cancer-patients-whole-genome-transcriptome", "https://techcrunch.com/2022/05/18/isabls-rapid-whole-genome-analysis-opens-the-playbook-for-cancer-treatment/"]}, "conflict": {"value": "360Dx reports undisclosed Two Sigma seed in July 2020; TechCrunch reports $3M seed announced May 2022 — unclear if separate tranches or re-announcement", "source_urls": ["https://www.360dx.com/molecular-diagnostics/msk-starts-offering-pediatric-cancer-patients-whole-genome-transcriptome", "https://techcrunch.com/2022/05/18/isabls-rapid-whole-genome-analysis-opens-the-playbook-for-cancer-treatment/"]}}, {"field": {"value": "ruo_release_timeline", "source_urls": ["https://www.isabl.io/technology"]}, "gap": {"value": "Company website stated Isabl GxT RUO release planned Q2 2024; no independent confirmation found that RUO launch occurred", "source_urls": ["https://www.isabl.io/technology"]}}, {"field": {"value": "fda_breakthrough_year", "source_urls": ["https://people.equilar.com/bio/org/isabl-inc/10595325", "https://www.360dx.com/molecular-diagnostics/msk-starts-offering-pediatric-cancer-patients-whole-genome-transcriptome"]}, "gap": {"value": "Equilar/Inknowvation cite 2021; 360Dx article date unclear on exact year; no primary FDA database citation retrieved", "source_urls": ["https://people.equilar.com/bio/org/isabl-inc/10595325", "https://www.360dx.com/molecular-diagnostics/msk-starts-offering-pediatric-cancer-patients-whole-genome-transcriptome"]}}]]
- source urls
- ["https://aeo.sig.ai/brands/isabl", "https://biobase.whitefordresearch.com/companies/isabl", "https://conductscience.com/sciencedex/institutions/isabl-inc", "https://geo.sig.ai/brands/isabl", "https://linkedin.com/in/andrew-kung-33a160231", "https://people.equilar.com/bio/org/isabl-inc/10595325", "https://techcrunch.com/2022/05/18/isabls-rapid-whole-genome-analysis-opens-the-playbook-for-cancer-treatment/", "https://tracxn.com/d/companies/isabl/__tCqM6mim5rFSa3O76LHcICp2rRqXci47XXjfSZQTL7s/funding-and-investors", "https://www.360dx.com/molecular-diagnostics/msk-starts-offering-pediatric-cancer-patients-whole-genome-transcriptome", "https://www.cbinsights.com/company/isabl", "https://www.inknowvation.com/sbir/companies/isabl-inc", "https://www.isabl.io/", "https://www.isabl.io/company", "https://www.isabl.io/technology", "https://www.linkedin.com/company/isabl", "https://www.mskcc.org/news/new-type-genetic-testing-aims-benefit-children-and-young-adults", "https://www.thecompanycheck.com/company/b/isabl/65n7msaimutrsrzz3", "https://www.ycombinator.com/companies/isabl", "https://www.ycombinator.com/companies/isabl/jobs"]